CSTL (STOCKS)
Castle Biosciences, Inc. Common Stock
$20.700000
-0.310000 (-1.48%)
Prev close: $21.010000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Derek J. Maetzold
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $627.22M
- Employees
- 823
- P/E (TTM)
- -48.20
- P/B (TTM)
- 1.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $339.92M |
| Benefits Costs and Expenses | $0.00 |
| Cost Of Revenue | $75.18M |
| Costs And Expenses | $373.21M |
| Gross Profit | $264.74M |
| Operating Expenses | $298.03M |
| Selling, General, and Administrative Expenses | $235.60M |
| Research and Development | $53.69M |
| Other Operating Expenses | $8.74M |
| Operating Income/Loss | -$33.29M |
| Income/Loss From Continuing Operations After Tax | -$12.83M |
| Income/Loss From Continuing Operations Before Tax | $258.26M |
| Income Tax Expense/Benefit | -$4.82M |
| Income Tax Expense/Benefit, Deferred | -$5.47M |
| Net Income/Loss | -$12.83M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$12.83M |
| Net Income/Loss Available To Common Stockholders, Basic | -$12.83M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.42 |
| Diluted Earnings Per Share | -$0.43 |
| Basic Average Shares | 87,994,000 |
| Diluted Average Shares | 88,625,000 |
| Assets | $547.81M |
| Current Assets | $328.90M |
| Inventory | $10.46M |
| Other Current Assets | $318.44M |
| Noncurrent Assets | $218.90M |
| Liabilities | $86.39M |
| Current Liabilities | $48.76M |
| Accounts Payable | $15.04M |
| Wages | $19.11M |
| Other Current Liabilities | $14.61M |
| Noncurrent Liabilities | $37.63M |
| Long-term Debt | $10.07M |
| Other Non-current Liabilities | $27.56M |
| Equity | $461.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $461.42M |
| Liabilities And Equity | $547.81M |
| Net Cash Flow From Operating Activities | $48.25M |
| Net Cash Flow From Operating Activities, Continuing | $48.25M |
| Net Cash Flow From Investing Activities | -$63.74M |
| Net Cash Flow From Investing Activities, Continuing | -$63.74M |
| Net Cash Flow From Financing Activities | -$10.44M |
| Net Cash Flow From Financing Activities, Continuing | -$10.44M |
| Net Cash Flow | -$25.93M |
| Net Cash Flow, Continuing | -$25.93M |
| Comprehensive Income/Loss | -$12.93M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$13.03M |
| Other Comprehensive Income/Loss | -$17.46M |